000 | 01445 a2200409 4500 | ||
---|---|---|---|
005 | 20250515091537.0 | ||
264 | 0 | _c20071213 | |
008 | 200712s 0 0 eng d | ||
022 | _a1120-6721 | ||
024 | 7 |
_a10.1177/112067210701700520 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYavas, G F | |
245 | 0 | 0 |
_aThe effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. _h[electronic resource] |
260 |
_bEuropean journal of ophthalmology _c |
||
300 |
_a812-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiparasitic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBenzothiazoles _xtherapeutic use |
650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
650 | 0 | 4 | _aMicroscopy, Confocal |
650 | 0 | 4 |
_aOptic Disk _xdrug effects |
650 | 0 | 4 |
_aParkinson Disease _xcomplications |
650 | 0 | 4 | _aPramipexole |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
650 | 0 | 4 |
_aRetinal Degeneration _xetiology |
650 | 0 | 4 |
_aRetinal Ganglion Cells _xdrug effects |
700 | 1 | _aYilmaz, O | |
700 | 1 | _aKüsbeci, T | |
700 | 1 | _aOztürk, F | |
773 | 0 |
_tEuropean journal of ophthalmology _gvol. 17 _gno. 5 _gp. 812-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/112067210701700520 _zAvailable from publisher's website |
999 |
_c17453586 _d17453586 |